Skip to main content

DSC Advisors, L.P.

SEC CIK
0001299434
Latest filing
Nov 14, 2024

Holdings in Q2 2023

Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.

Institution overview
Positions
25
+6 vs. Q1 2023
Portfolio value
$63.6M
+$11.0M (+20.9%) vs. Q1 2023
Filed
Aug 14, 2023
SEC
Holdings of DSC Advisors, L.P. in Q2 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
RCMR1 RCM Inc.COM841,000$15.5M24.4%−149,000−15.1%ReducedHistory
CVSCVS Health CorpStock153,237$10.6M16.7%+22,957+17.6%AddedHistory
ZBHZimmer Biomet Holdings, Inc.Stock62,534$9.10M14.3%+50.0%AddedHistory
BMRNBiomarin Pharmaceutical IncCOM100,000$8.67M13.6%+7,500+8.1%AddedHistory
GOOGAlphabet Inc.Stock46,000$5.56M8.7%00.0%UnchangedHistory
ABTAbbott LaboratoriesStock41,415$4.52M7.1%+41,415NewHistory
EHTHeHealth, Inc.COM380,000$3.06M4.8%+187,500+97.4%AddedHistory
TEVATeva Pharmaceutical Industries LtdSPONSORED ADS310,000$2.33M3.7%+130,000+72.2%AddedHistory
YARWYarrow Bioscience, Inc.COM115,000$466.9K0.7%00.0%UnchangedHistory
MSFTMicrosoft CorpStock1,073$365.4K0.6%−177−14.2%ReducedHistory
GOOGLAlphabet Inc.Stock2,865$342.9K0.5%−600−17.3%ReducedHistory
METAMeta Platforms, Inc.Stock1,192$342.1K0.5%−153−11.4%ReducedHistory
VVisa Inc.Stock1,290$306.3K0.5%+245+23.4%AddedHistory
MAMastercard IncStock759$298.5K0.5%+137+22.0%AddedHistory
ADBEAdobe Inc.Stock534$261.1K0.4%+534NewHistory
ACNAccenture plcStock813$250.9K0.4%+813NewHistory
ZVRAZevra Therapeutics, Inc.COM NEW49,100$250.4K0.4%+49,100NewHistory
CRMSalesforce, Inc.Stock1,184$250.1K0.4%+130+12.3%AddedHistory
AAPLApple Inc.Stock1,190$230.8K0.4%−218−15.5%ReducedHistory
ORCLOracle CorpStock1,921$228.8K0.4%+1,921NewHistory
NFLXNetflix IncStock519$228.6K0.4%+519NewHistory
BRK.BBerkshire Hathaway IncStock628$214.1K0.3%+628NewHistory
EHABEnhabit, Inc.COM10,000$115.0K0.2%+10,000NewHistory
SEATVivid Seats Inc.COM CL A10,000$79.2K0.1%+10,000NewHistory
Comsovereign Hldg Corp205650401COM NEW22,500$38.5K0.1%+22,500New–

Options (3)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of DSC Advisors, L.P. in Q2 2023
SecurityClassPutsCalls
BMRNBiomarin Pharmaceutical IncCOM$2.17M–
ZVRAZevra Therapeutics, Inc.COM NEW–$671.7K
HBIHanesbrands Inc.COM–$227.0K

Sold out since Q1 2023 (4)

Positions held at the end of Q1 2023 that are gone from this filing.

Positions of DSC Advisors, L.P. sold out since Q1 2023
SecurityClassShares in Q1 2023Value in Q1 2023% of portfolio in Q1 2023History
ProShares Tr74347B201PSHS ULTSH 20YRS10,000$279.6K0.5%–
Advisorshares Tr00768Y453PURE US CANN ETF27,500$156.5K0.3%–
DISHDISH Network CORPCL A15,000$139.9K0.3%History
Invesco QQQ Trust Series I46090E103ETF41$13.2K<0.1%–